Literature DB >> 33530207

Clinical investigation of nosocomial infections in adult patients after cardiac surgery.

Zhengqin Liu1, Xiquan Zhang, Qian Zhai.   

Abstract

ABSTRACT: Nosocomial infections (NI) are common complications after cardiac surgery. To date, there have been few manuscripts investigating NI in the intensive care unit after cardiac surgery. Our study was designed to investigate the characteristics of the distribution of pathogenic bacteria, antibiotic resistance and risk factors for NI.A total of 1360 patients received standard postoperative care, including antibiotic prophylaxis. Microbiological examinations of sputum, blood, catheter tips and excrement were performed as clinically indicated to isolate pathogens. Thirty potential associated variables were collected and compared between the 2 different groups according to the development of NI using univariate and multivariate analyses.Eighty-nine patients (6.54%) acquired a microbiologically documented NI. There was a significant difference in mortality between the 2 groups with or without postoperative NI (23.60% vs 2.28%, P < .00). A total of 98 pathogens (73.13%) were isolated from sputum, 32 pathogens (23.88%) from blood and only 1 (0.75%) from urine. Three (2.24%) surgical site infections were detected, including 2 superficial surgical site infections and 1 mediastinitis. The most common pathogens were Gram-negative bacteria (78.36%), followed by Gram-positive bacteria (14.93%) and fungi (6.71%). The major pathogenic species had different levels of drug resistance, and most of them exhibited multidrug resistance. Six out of thirty variables were identified as independent risk factors for the development of NI, namely, duration of surgery, low cardiac output syndrome, continuous veno-venous hemofiltration, mechanical ventilation time, reintubation and tracheostomy.We analyzed the characteristics of the distribution of pathogens, antibiotic resistance and risk factors for NI in our center and provided some suggestions for clinical practice. In addition to antibiotic treatment, avoidance of risk factors and aggressive infection control measures may be crucial to stop or prevent outbreaks.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33530207      PMCID: PMC7850681          DOI: 10.1097/MD.0000000000024162

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  23 in total

Review 1.  Emerging opportunistic yeast infections.

Authors:  Marisa H Miceli; José A Díaz; Samuel A Lee
Journal:  Lancet Infect Dis       Date:  2011-02       Impact factor: 25.071

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

Review 3.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

4.  Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States.

Authors:  Hilmar Wisplinghoff; Tobias Paulus; Marianne Lugenheim; Danuta Stefanik; Paul G Higgins; Michael B Edmond; Richard P Wenzel; Harald Seifert
Journal:  J Infect       Date:  2011-12-20       Impact factor: 6.072

Review 5.  Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.

Authors:  Marie Kempf; Jean-Marc Rolain
Journal:  Int J Antimicrob Agents       Date:  2011-11-22       Impact factor: 5.283

6.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

7.  Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.

Authors:  Sibylle H Lob; Daryl J Hoban; Daniel F Sahm; Robert E Badal
Journal:  Int J Antimicrob Agents       Date:  2016-03-05       Impact factor: 5.283

8.  Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.

Authors:  Ruthy Tal-Jasper; David E Katz; Nadav Amrami; Dor Ravid; Dori Avivi; Ronit Zaidenstein; Tsilia Lazarovitch; Mor Dadon; Keith S Kaye; Dror Marchaim
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

9.  Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.

Authors:  Ofelia C Tablan; Larry J Anderson; Richard Besser; Carolyn Bridges; Rana Hajjeh
Journal:  MMWR Recomm Rep       Date:  2004-03-26

10.  Control of endemic extensively drug-resistant Acinetobacter baumannii with a cohorting policy and cleaning procedures based on the 1 room, 1 wipe approach.

Authors:  Laura Gavaldà; Ana M Soriano; Jordi Cámara; Rosa Gasull; Olga Arch; Montserrat Ferrer; Evelyn Shaw; Rosa M Granada; M Angeles Dominguez; Miquel Pujol
Journal:  Am J Infect Control       Date:  2016-01-29       Impact factor: 2.918

View more
  2 in total

1.  Investigation and Analysis of Infection among Inpatients in a Tertiary Hospital in Shanghai.

Authors:  Jiao Yu; Jing Wang; Xinying Fang; Feihu Huang
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

Review 2.  Nosocomial Extracardiac Infections After Cardiac Surgery.

Authors:  Enrico Maria Zardi; Massimo Chello; Domenico Maria Zardi; Raffaele Barbato; Omar Giacinto; Ciro Mastoianni; Mario Lusini
Journal:  Curr Infect Dis Rep       Date:  2022-09-24       Impact factor: 3.663

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.